Kabi International Growth Study (KIGS) is a ... | |
Kabi International Growth Study (KIGS) is a long, surveillance study of pediatric patients being treated for GHD since 1987. Adverse effects of HGH supplementation have been followed by mandatory prospective data collection.
The most common tumor associated with the etiology of growth hormone deficiency is craniopharyngioma. In comparing patients who received supplemental growth hormone and patients who did not, the data revealed that the reoccurrence rate is dramatically less in the supplemental group. In fact, KIGS seems to suggest an argument against growth hormone having oncogenic potential of significance. Another recent study out of Memorial Sloan-Kettering Cancer Center further concluded that growth hormone therapy does not appear to carry any additional risk of disease reoccurrence or death in survivors of childhood cancer.
Articles: [ Prev 1 2 3 4 5 6 7 8 Next ]